Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

12 Health Care Stocks Moving In Thursday's After-Market Session

Author: Benzinga Insights | September 04, 2025 05:13pm

Gainers

  • iSpecimen (NASDAQ:ISPC) shares rose 52.4% to $1.0 during Thursday's after-market session. The market value of their outstanding shares is at $5.5 million.
  • Mobile-health Network (NASDAQ:MNDR) stock moved upwards by 7.85% to $1.03. The market value of their outstanding shares is at $5.6 million.
  • Calidi Biotherapeutics (AMEX:CLDI) stock moved upwards by 7.61% to $1.69. The market value of their outstanding shares is at $8.4 million.
  • Fortress Biotech (NASDAQ:FBIO) shares moved upwards by 7.03% to $3.04. The market value of their outstanding shares is at $87.7 million.
  • Tempest Therapeutics (NASDAQ:TPST) stock rose 6.88% to $10.71. The company's market cap stands at $46.6 million.
  • Hyperfine (NASDAQ:HYPR) shares moved upwards by 6.24% to $1.19. The market value of their outstanding shares is at $88.0 million.

Losers

  • Indaptus Therapeutics (NASDAQ:INDP) shares declined by 13.2% to $4.0 during Thursday's after-market session. The market value of their outstanding shares is at $5.9 million.
  • Phreesia (NYSE:PHR) stock decreased by 11.89% to $27.5. The market value of their outstanding shares is at $1.8 billion. The company's, Q2 earnings came out today.
  • Relmada Therapeutics (NASDAQ:RLMD) stock declined by 6.57% to $1.28. The market value of their outstanding shares is at $48.7 million.
  • Sutro Biopharma (NASDAQ:STRO) shares fell 6.26% to $0.97. The market value of their outstanding shares is at $85.6 million.
  • Cencora (NYSE:COR) stock fell 6.05% to $275.0. The market value of their outstanding shares is at $57.2 billion.
  • Predictive Oncology (NASDAQ:POAI) stock declined by 5.97% to $0.86. The market value of their outstanding shares is at $9.8 million. See Also: www.benzinga.com/money/best-healthcare-stocks/

This article was generated by Benzinga's automated content engine and reviewed by an editor.

Posted In: CLDI COR FBIO HYPR INDP ISPC MNDR PHR POAI RLMD STRO TPST

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist